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It has been known since the time of Alexander Schmidt (32) that throm- 
bin  disappears  rapidly  from  the  serum  after  blood  clotting.  Isolated 
prothrombin and thrombin preparations vary in stability on keeping and 
on heating (8,  21,  30),  and thrombinolysis by added trypsin is known to 
reduce its effectiveness in dotting blood (7,  11).  A  study of  the  kinetics 
of the reduction in coagulant activity of thrombin preparations,  (a)  held 
under controlled physical conditions,  (b)  as influenced by added trypsin, 
and (c) in the presence of serum, might be expected to shed light on the 
mechanism of thrombin inactivation. 
Any factor which prolongs the clotting time of fibrinogen by thrombin 
might very well be termed an "antithrombin," but the term suffers from 
various ill-defined restrictions of usage.  A distinction may be drawn be- 
tween thrombin-inhibitors which produce their full effect immediately and 
those  which  act  progressively.  Examples  of  "immediate"  antithrombic 
action  are  the  effects of  pH,  salts,  etc.,  especially including polyvalent 
anions and heparin (12, 16).  Thrombinolysis is essentially a "progressive" 
phenomenon, and since the progressive character of the classical antithrom- 
bins has long been recognized (4, 17), there is obvious need for clarification 
of  the  relations  between thrombinolysis and  the  antithrombic  action  of 
serum in vitro and in vivo.  The present enquiry into the general charac- 
teristics of the process of progressive thrombin inactivation (in vitro) may 
assist in the approach to these problems. 
I 
Reagents and Methods 
Full  details  of  our  routine  methods  of preparing  the  various  clotting 
agents are given in a previous publication (9).  Appended  are some addi- 
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tional  technical  considerations  relating  to  modifications  of  the  methods 
and  the  special  requirements  of the  current  investigations: 
Preservation of Reagents; Apparatus  Used; etc.--Low temperatures (ice box) are used 
for the preservation of solutions.  In all cases, a  few crystals of thymol are added to 
prevent bacterial growth.  The glass electrode (Beckman pH meter)  is used to control 
pH, and the specified  temperatures are maintained  (:t:0.5°C.) with a thermostat water 
bath.  A  mechanical  rocking device  and  stop  watch  are  used  in  timing  coagulation 
(see below). 
Protkrombin Solutions.--The  Howell-type "prothrombin papers," each corresponding 
to  5  cc.  of filtrate  from defibrinated  (55°C.),  Berkefelded,  citrated  dog plasma,  are 
extracted in the cold for 1-2 hours with distilled water and a drop or two of 0.5 per cent 
NaHCOn.  The pH of the filtered extract is adjusted to pH -- 7.2 with N/10 acetic acid. 
Activity.--In some recent tests, kindly performed for us by Dr. H. P. Smith (Iowa), 
it was found that the activity of such prothrombin solutions represents some 57 per cent 
of a corresponding volume of (average) dog plasma.  1 co. of solution (3 papers +  60 co. 
water)  contained 1.25 rag. (total) N  and assayed 47 prothrombin "units"  (Smith et al. 
(36)); i.e., activity  -  38 units per mg. N. 
The nitrogen (protein)  content of the prothrombin solution was sometimes reduced 
by  submitting  the  above  salt-poor  extract  to  isoelectric  precipitation  (pH  --  5.3). 
On redissolving to original volume and routine pH (7.2),  there was no significant loss 
in potency.  Other prothrombin methods were tried, e.g. Mellanby's (21); also various 
adsorbed and eluted preparations (e.g. (34)), without finding any significant modification 
of  the properties to be  described.  There was a  suggestion that preliminary Berkefeld 
filtration of the plasma favored the subsequent preparation of a more stable prothrombin, 
but details have not been worked out. 
Tkrombin.--Is  formed from prothrombin solution by activating to maximal coagulant 
activity with optimal amounts of N/10 CaCI~ and a  thromboplastic agent (cephaliu or 
brain thromboplastin~ee below).  The pH is finally adjusted to 7.0 (unless  otherwise 
stated).  Like Mellanby (21) and others (35),  we found that the  final  thrombin could 
be precipitated by acetone.  The precipitate, whether dried immediately or kept under 
the acetone, has yielded active preparations, even after several months (ice box). 
Tkromboplastin.--The  cephalin  has  been  described  previously  (9).  Mter  some  2 
years under  alcohol it  suffered considerable  loss of potency and yielded solutions  of 
noticeable acidity.  A crude but potent thromboplastin is prepared by grinding up dog 
brain (fresh or frozen) with distilled water, diluting, and centrifugalizing.  A desiccated 
preparation was also made by precipitating a saline (0.85 per cent NaC1) extract of brain 
with four volumes of acetone, recovering the deposit on a Bfichner funnel, and drying 
at room temperature.  Aqueous suspensions were made up as required. 
Fibrinogen.--(NH4)2SO4-fibrinogen is  made from Berkefelded  plasma  in  the  usual 
way (9).  A low salt content favors a sharp end-point in the clotting test  (see below); 
hence the use of water, rather than saline,  as the solvent and the avoidance of citrate 
(or oxalate), which might be desirable,  theoretically,  to control traces of prothrombin 
(8).  Actual tests reveal little or no prothrombin, provided that the fibrinogen is made 
from Berkefelded plasma several days old and particularly if a well diluted fibrinogen 
solution  is  employed.  It  is  unnecessary  to  resort  to  the  previously  recommended 
adsorption techniques (9) for getting rid of the last traces of prothrombin.  Lyophilized A. J.  GLAZK0  AND  J.  H. PERGUSON  171 
fibrinogen (10) has been found to lose all traces of prothrombin on simple keeping, but 
was not used in the current experiments.  A new and easy method of preserving fibrino- 
gen consists in dissolving the final salted-out protein in 20 per cent urea solution.  Stored 
in the ice box, such preparations  keep for several weeks.  At low temperatures the urea 
protects the fibrinogen from denaturation, according to Diebold and Jtihling (5).  It is 
restored to a state closely resembling the original on removing the urea (a) by dialysis 
through Visking casing or (b) merely by diluting (10-30 times) to a point at which the 
urea ceases to exert a significant influence on dotting (16).  Traces of prothrombin,  if 
present in the fibrinogen, are apt to be preserved  also and occasionally lead to some 
thrombin formation which causes traces  of clot to appear in the recovered fibrinogen. 
Any unstable fibrinogen preparation, of course, is discarded. 
Crystalline Trypsin.--Is  now  available  commercially, t  The  preparation  we  used 
contained 0.022 rag. protein N per rag. of sample. 
Serum.--The mode of preparation and testing of serum antithrombin will be described 
in the appropriate  section. 
Barbiturate Buffer.--In certain experiments,  involving alteration of the pH of the 
thrombic mixtures, constancy of the hydrogen ion concentration in the actual thrombin- 
fibrinogen  interaction was  secured  by adding an equal  volume  of N/10  barbital-Na 
(Michaelis (24)), at the routine pH (7.2), to the fibrinogen solution, and checking with 
the glass electrode.  We  have also used the expensive imidazole buffer recommended 
by Mertz, Seegers, and Smith (23), in several of the cited experiments. 
Clotting  Time  and  Thrombin  Concentration  (Relative):  the  "Inverse  Law" 
All methods of  thrombin  (and prothrombin)  determination  are  neces- 
sarily relative, since the agent has not yet been defined chemically.  In the 
current  investigation,  thrombin  "concentrations"  are  initially  expressed 
in terms of the degree of dilution of the same preparation,  used as the stand- 
ard of reference throughout the particular experiment.  We have avoided 
any  attempt  to  transfer  the  quantitative  data  from  one  experiment  to 
another by means of arbitrary thrombin units (cf.  6). 
The index of activity of thrombin in a given test is the clotting time (see 
below) for a  suitable fibrinogen solution.  The dependence of cldotting time 
upon  physical conditions  (temperature,  pH,  salt  content,  fibrinogen con- 
centration, etc.) makes it imperative to control all these variables through- 
out each series of tests.  The influence of naturally-occurring antithrombins 
is  also  an  important  variable  which will  receive  special  consideration in 
other sections of this paper. 
Many previous workers  (e.g.  14)  have established  the general principle 
known as the inverse law, which states that the clotting time is an inverse 
(reciprocal)  function  of  thrombin  concentration.  This  expression  is 
analogous to the well known Arrhenius "Qt rule" (1, 2),  developed for  re- 
i Plaut  Research  Laboratory, Lehn and Fink Products  Corporation,  Bloomfield, 
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lating enzyme concentration to  the  time:required  for the  production of a 
given amount  of effect.  The formulation reads 
E.y = K  (1), 
i.e.  the product of enzyme concentration E  by time y  is  a  constant  (K). 
Alternatively, 
K 
E  ffi  -  (2), 
Y 
i.e.  enzyme  concentration  bears  an  inverse  relation  to  the  time  factor. 
Without committing oneself to any hypothesis of the actual identification 
TABLE I 
Relation of Clotting  Time to Thrombin Concentration 
A 
B 
E 
(relative 
concentration) 
100 
80 
60 
40 
20 
64 
32 
16 
8 
4 
20 
25 
35 
55 
115 
E.y 
2000 
2000 
2100 
2200 
2300 
25 
29 
45 
72 
105 
1600 
928 
720 
576 
420 
(y-a) 
Where ~ ffi= --5 
2500 
24OO 
24OO 
24OO 
24OO 
Where a =~ 18 
448 
353 
430 
430 
348 
A  =  MeUanby-type (21) thrombin. 
B  -- Howell-type prothrombin (9)  +  Ca +  brain thromboplastin. 
of thrombin with the enzymes (of.  27), "thrombin"  may be substituted for 
"enzyme" in the mathematical  analysis of the data. 
When  applying the  formula to  coagulation data,  we  may question  the 
validity of postulating the "given amount of effect," viz.  here the identical 
extent of change in fibrinogen at  the moment of coagulation,  irrespective 
of the amount or type of thrombin used.  Actually, the only evidence for 
this  is  the  reasonably  close  adherence  to  the  inverse law  throughout  the 
range of thrombin concentrations with which we are working.  There are 
undoubted empiricisms of technique, particularly in the method of timing 
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We thne the appearance of the first visible strands of fibrin in a relatively weak and 
salt-poor  fibrinogen  solution.  This  timing from  the  commencement  of  clotting is 
readily applicable to the translucent solutions with which we are working.  It is particu- 
larly valuable for the weakest thrombins, which may fail to cause gel formation.  Meth- 
ods of timing based on solidity (firmness) of the dot (e.g. time when tube can be inverted 
without spilling the contents), while frequently used for such turbid materials as whole 
blood, etc., are obviously subject  to additional variables  such as the adhesiveness and 
coherence of the fibrin gel and the diameter of the tube used in the clotting test. 
To test the applicability of equation 2, serial dilutions of a typical throm- 
bin preparation were used.  0.5  cc. of each dilution was added to  1.0 cc. 
of weak  fibrinogen solution  at  the  routine  temperature  (20°C.)  and  pH 
(7.2),  and  the  clotting  time  noted.  The  results  are  listed  in  Table  I, 
Series  A. 
The  product  of  clotting  time  by  concentration  (relative  dilution)  of 
thrombin gives a  value which is constant within the limits imposed by the 
experimental  technique.  Equation  2  does fit the experimental data and, 
therefore, affords a means of assaying thrombic activity by timing the clot. 
Thrombin concentrations are henceforth computed from the actual clotting 
time data, the validity being checked by a  similar series of dilution experi- 
ments accompanying each of the subsequent investigations.  2 
Equation 2 represents a  special case of the general equation for a linear relation, 
(1_ b)+ m  (i),  E 
where b is a constant determined by the Y-axis intercept of the line obtained by plotting 
1 
- against E, and m is the slope of the line.  b =  0 in the special case of equation 2, and, 
Y 
since b is usually quite small, this equation affords a sufficiently good approximation 
to the actual experimental  conditions to serve the purposes of the present paper.  In 
some of the data, closer agreement with the theoretical conditions  is  attained by the 
use of the general formula.  Thus, the derived expression for the rate constant (k, equa- 
tion 6) would be modified to 
(}-0  k= ~  log,0 (y  1  b)  (ii). 
A more manageable form of equation (il) may be developed from the observation that K 
(ffi Ey; equation 1) varies directly with E, whence 
K  =  Ey =  aE 4- ¢  fffQ, 
or 
E •.  ¢  (iv), 
where c is a constant, determined by the intercept with the Y-axis of the line obtained 
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Kinetics of Thrombin Inactivation:  Order of the Reaction 
Provided we know the order of the reaction, the rate of the progressive 
inactivation of thrombin can be defined by the constant of the rate equa- 
tion.  The expression for a first order inactivation process is 
dE 
-  a-7  =  k.E  (3), 
or, integrating between the limits of the incubation times tl and ts (and cor- 
responding thrombin concentrations E1 and E~.) 
--2.3 logx0 (E~I)= k (h--'l)  (4). 
N  / 
Substituting K__ for E  (equation  2), we obtain 
Y 
--  2.3 logt0 y  l  =  k (ts -  tl)  (5), 
Ys 
or 
,0,  k =  (~,  _  t------~ 
fO00 
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Fzc.  1.  Effect of thrombin concentration on the 
rate of inactivation (pH  7.0; temperature 38°). 
where  k  is  the  velocity 
constant  for  a  first  order 
reaction,  representing  the 
fraction of thrombin inacti- 
vated in unit time (a minute 
being used as the time  unit 
throughout this  paper). 
The  experimental results 
of Fig.  1 were obtained in a 
study of the rate of "spon- 
taneous"  inactivation  of  a 
thrombin prepared from the 
Howell-type  prothrombin 
with CaC12 and brain throm- 
boplastin, as described under 
2.3  (y,  -  a'~ 
k =" ~  logx0 MY1 -- a/  (v). 
That this relation holds more widely than E  =  K  is shown by a comparison of the last 
y 
two columns of Table I, especially for Series B.  This expression may be used to extend 
the experimental validity of equation 6. 
reagents.  The  clotting  time  data  were  substituted  into  equation  6. A.  J.  GLAZKO  AND  J.  H.  FERGUSON  t75 
The  values of y  are  routinely determined from the  "best"  straight  line 
drawn through the points,  using the method of least  squares  (22).  The 
calculated k values are given in Fig. 1. 
The  values of k  for different concentrations of thrombin are constant, 
within  experimental limits.  This  has  been' confirmed repeatedly during 
these  studies.  It  establishes  the  fact that  the inactivation of thrombin 
follows the course of a  first order reaction.  Calculations based upon the 
assumption of zero order and of second order reactions gave variable values 
for k. 
A generalized formulation of the results iUustrated in Fig.  1 is 
dy  K t 
= 2  (7) 
This brings out the additional point that, although the fraction of throm- 
bin inactivated in unit time is constant irrespective of the thrombin con- 
TABLE  II 
Variation of k for Different Tkrombin Preparations 
The thrombin preparations were made from the Howell-type prothrombin by acti- 
vation with CaC1, and the designated thromboplastin.  The values for k were  obtained 
at pH 6.0 and 38  °. 
Brain extract  CephaUn 
*  Acetone-precipitated thrombin (see  reagents). 
centration, the rate of increase in the clotting time is greater for weak throm- 
bin preparations than for stronger ones. 
Variation of k for Different Tkrombin Preparations:  Influence of 
Thromboplastin 
Although many types of active thrombin (crude) have been described in 
the literature (see section on methods), all preparations are empirical and 
make no claim to chemical purity.  The data summarized in Table II show 
fairly wide variations of the k  value for different thrombin preparations. 
This is true for a large number and variety of thrombin preparations which 
have been investigated.  It even holds for solutions made on different oc- 
casions with exactly similar techniques of preparation.  The  question Of 
the possible influence of the type of thromboplastic agent used in activation 
is especially important in view of the possibility that this may contribute a 
thrombinolytic factor (in crude tissue extracts, for instance). 176  KINETICS O~g  ~ROMBIN II~Ac~IVATION 
Fig. 2 gives the complete activation, and subsequent inactivation curves 
for  a  weak  prothrombin  solution,  converted  into  thrombin  by  a  fixed 
2s 
2(:  "~  .,  ' 
•  ,~ 
5' 
t-  minutes 
Fzo. 2.  Changes in coagulant activity produced by 
the activation  of a  weak prothrombin  preparation 
with Ca  ++ and different concentrations of cephalin 
(pH 8.0; temperature 38°). 
amount of ~T/10 CaCh  and 
varying amounts of a ceph- 
alin preparation.  There is 
some  inhibitory  effect on 
thrombin  formation  with 
the higher cephalin concen- 
trations, due perhaps to the 
large excess of cephalin  in 
relation  to  the weak p~o- 
thrombin  used  (8).  The 
chief effect appears  to  be 
immediate, since an analy- 
sis of the linear portion ot 
the  inactivation  curves 
shows only a  threefold in- 
crease  in  the  k  value  for 
a  16-fold increase in ceph- 
alin  concentration. 
Table III shows the effects of varying amounts of (A) cephalin, added to 
fully formed thrombin and (B) brain thromboplastin, added to recalcified 
TABLE  HI 
Influence of Tkromboplastin on k (pH  =  7.5; temperature  =  38  °) 
Clotting times (seconds) given in body of tables. 
A.  Cephalin Added to a Fully Formed Thrombin 
Final concentration  Incubation time (minutes)  k 
of cephalin  30  ~  60'  120'  360'  (approximate) 
1:6000  44"  50"  65"  130"  0.003 
1 : 12,000  42"  42"  53"  125"  O. 003 
I : 24,000  42"  47"  62"  120"  0.003 
None added  33"  37"  44"  130"  0.004 
B.  Brain Tkromboplastin Added to a Weak Protkrombin (Recalcified) 
Relative 
comcentr&tion 
of brain 
extract  6' 
41" 
30" 
28" 
Incuhttion time (minutes) after recalciflcafion 
20'  60  ~  120  t  280' 
5o.  7o"  f  6o"  I  68" 
43"  65"  65"  78" 
42"  [  70"  [  70"  [  I00" 
k 
{approxi- 
1440'  mate) 
180"  0.0010 
250"  0.0015 
315"  0.0017 A. J.  GLAZK0  AND  J.  H. ~FERGUSON  177 
prothrombin.  The  k  values  for  the  respective  inactivation  processes 
again show very little dependence on concentration of the thromboplastic 
factor. 
The addition of saliva (another thromboplastic agent (15))  had no effect 
on  the  velocity  constant. 
These studies are by no means exhaustive and should be extended to a 
wider variety of thromboplastic agents.  For present purposes, the cited 
data suffice to uphold the contention that the major factor in the k varia- 
tions of the individual thrombins is not significantly related to the throm- 
boplastin. 
II 
Influence of Physical Conditions,  Trypsin, and Serum. 
Influence of Physical Conditions 
(A).  Temperature.--The older literature (27) contains frequent reference 
to  the instability of thrombin at  elevated temperatures.  Table  IV pre- 
sents the results of kinetic studies on various thrombins at different tem- 
peratures. 
The critical thermal increment (it) was calculated from the integrated form 
of the van't Hoff-Arrhenius equation 
4.6T1T2  (le~) 
z = (n-  n-----) log~0  (s), 
where g  represents the  critical  thermal increment  ("activation energy") 
in calories per tool, kl and k~ are the velocity constants, calculated from 
equation 6,  for the absolute temperatures Tx and I"2, respectively. 
The values for Qx0 were computed from the formula 
,0  C') 
log Qlo -  (T,--TI-~) log  k-x  (9). 
The following points are brought out in the data: 
1.  Below  15°C.,  the rate  of inactivation becomes very  small and  the 
increase of k with rise of temperature (as indicated by the Q~o) is very minor. 
This  resembles  many  enzyme  reactions  (38).  It  also  emphasizes  the 
necessity of running clotting tests at low temperatures to prevent loss of 
thrombic activity (especially during the activation of weak prothrombins) 
during any prolonged clotting tests (9). 
2.  Between 20°C. and 40°C., the value of g  is of the same order as that 
obtained in many known chemical and enzymatic reactions (e.g. 38). 
3.  Above 50°C.  (especially near 60°C.), the value  of it  increases  mark- 178  KINETICS  OF  THROMBIN INACTIVATION 
edly to over 40,000  calories  per mol  (at  constant  pH).  Such high  values 
(under similar conditions)  are characteristic  of the thermal  denaturation  of 
proteins  (3)  and  the  heat  inactivation  of enzymes  (38)  and  viruses  (18). 
There is,  therefore,  a  definite  suggestion  that,  at about 60°C.,  thrombin  is 
directly influenced by heating.  This would be the case if thrombin  were a 
protein,  or  so  closely associated  with  proteins  as  to  be  affected  by their 
thermal  denaturation.  Strong  thrombin  preparations  may  retain  a  fair 
TABLE IV 
Influence of Temperature on k 
['hromboplnstin 
Cephalin 
Cepha!!n 
Cephalin 
Cephalin 
Brain 
Brain 
Treatment 
Acetone-thrombin 
Thrombin extracted 
with alcohol-ether 
Acetone-thrombin 
pH 
5.6 
7.0 
7.0 
7.2 
7.2 
7.2 
T*C. 
40.0 
40.0 
50.0 
50.0 
55.0 
55.0 
55.0 
15.0 
38.0 
7.5 
15.0 
25.0 
38.0 
49.0 
59.0 
7.5 
20.5 
38.0 
49.0 
59.0 
kX104 
8 
11 
37 
39 
64 
59 
70 
9 
30 
0 
2 
3 
11 
32 
249 
0 
5 
14 
9 
249 
t 
24,400 
22,500 
} 9,070 
}  6,830 
18,500 
39,800 
}  10,700 
} 71,000 
Q1o 
3.4 
2.8 
1.7 
1.5 
2.8 
7.8 
1.8 
27.7 
degree of activity, however, even after boiling for a  few minutes  (8).  The 
presence  of  water  is  apparently  essential  for  denaturation  (3).  When 
dried,  thrombin  preparations  are  much  more  stable  to  heating  (21)  and 
storing (35, 30) than when in solution. 
There is an unexplained  variability between the different thrombin  prep- 
arations  (Table IV).  In enzyme systems, which show analogous behavior, 
such  variability  is  often  associated  with  the  impurities  present  in the 
preparations,  although  many  of the  essential  data  are  the  same  for  crude 
preparations  as  for  highly  purified  enzymes  (37).  In  analogous  systems, 
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negative catalysts  (inhibitors),  their effectiveness being lessened by dilu- 
tion  (18).  Such an explanation may account for the greater stability of 
highly  concentrated  thrombin  solutions,  and  for  the  marked  deviations 
from the inverse law which they exhibit. 
The k values for the data on temperature effects were obtained at con- 
stant pH.  It has been pointed out that, for certain thermal denaturation 
reactions  (e.g.  pepsin),  where the rate varies with the hydrogen ion con- 
centration,  the  practice  of  measuring  the  critical  thermal  increment  at 
constant pH gives an unduly high value due to the inclusion of "the heat 
of  dissociation  of  all  acidic  equilibria  involved  in  preparing  the  initial 
molecules for the kinetic step of activation" (La Mer, 20).  Since our prep- 
arations  are  admittedly 
crude,  we  do  not  propose 
to  elaborate upon temper- 
ature and pH interrelation- 
ships,  but  merely to  state 
that the calculations for the 
critical  thermal  increment 
are subject to a  correction. 
The  effect  of  pH  on  the 
velocity  constant  is  dealt 
with  in  the following  sec- 
tion. 
(B).  pH.--In  studying 
the  influence  of  hydrogen 
ion  concentration  on  the 
rate of thrombin inactiva- 
150I  / 
/ 
pH 
FIG. 3. Effect of pH on  the  velocity constants 
of various thrombin preparations (temperature 38°). 
tion,  the  thrombin preparations are  adjusted  to  definite pH values (with 
the glass electrode) and the inactivation rate is measured at 38°C.  All clot- 
ting tests are made on fibrinogen, buffered with barbital at pH =  7.2.  The 
results are given in Fig. 3. 
In all cases, the rate of inactivation below a pH of about 3.5 is too great 
for  measurement.  The  acid-inactivated thrombin is  not  reactivated by 
neutralization.  The  most  stable  thrombin  preparations  show  very little 
change of k between pH 5.0 to 10.0.  Unstable preparations, including those 
to which trypsin or serum was added (see below), are most stable at pH of 
4 to 5 and become less and less stable as the alkalinity is increased,  The 
probable significance of these results will be brought out later, in the light of 
the additional experiments with trypsin and serum. 180  KINETICS  OF  THROMBIN  INA.CTIVATION 
Influence of Added Trypsin 
Crystalline trypsin (26) is a purified preparation of a well known protease, 
which has a  recognized ability to destroy thrombin (7,  11). 
In the experiments illustrated in Fig. 4, known amounts of crystalline 
trypsin were added to thrombin, at pH  =  8.2 and temperature  =  38°C. 
The k values were computed, as usual, from the clotting times, at various 
periods after the addition of trypsin.  It is evident that  the k values in- 
crease in direct proportion to the amount of trypsin added. 
The similarity of the calculated and observed values for k in Table V is 
striking evidence in support of the postulate that the rate of thrombin in- 
activation is indeed directly 
400 
/ 
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,o.  S 
4  8  12  20  40  80 
~inute~J  after  addition  of %rypsin 
FIG. 4. Effect of trypsin on the velocity constant 
(pH 8.2; temperature 38°). 
proportional to the trypsin 
present,  as  well  as  to  the 
concentration  of thrombin 
(equation 3).  The full re- 
sults may now be expressed 
as follows: 
dE ffi  kt.E.L  (10), 
dt 
differing from  equation  3, 
in  the  introduction of  the 
factor  L, which represents 
the  concentration  of  the 
thrombinolytic  factor 
(trypsin).  This  equation 
describes a  first  order inactivation reaction and  is a  generalized equation 
representing  the  kinetics  of  progressive  thrombin  inactivation.  It  is  ob- 
vious that once a  thrombin unit is chosen, the lysin unit is readily defined. 
Influence of Serum 
The classical studies of Howell (17), and the long-forgotten but significant 
data of Collingwood and MacMahon (4), include mention of the progressive 
character  of the antithrombic action of serum.  Heating serum to 60°C. 
for a  few minutes is said to destroy most of the antithrombic properties. 
Howell's contention that the action is associated with the serum proteins 
is supported by Quick (29), who, contrary to Howell and his pupils, finds a 
thermolabile  "albumin"  fraction  effective.  In  our  earlier  experiments 
(12)  no  significant  antithrombic  action  was  demonstrable  with  a  crude 
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incubating similar crude plasma albumin with a  stable thrombin for a  full 
hour, at 24°C., and noting only a  15 second increase over the original dot- 
ting  time  of  18  seconds  (maintained  unchanged  in  the  control).  Tests 
have also been made with a pure crystalline serum albumin, kindly supplied 
by  Dr.  T.  L.  McMeekin  (Harvard),  which  fail  to  demonstrate  any sig- 
nificant antithrombic action alone, and (in sharp contrast to crude albumin) 
in the presence of heparin.  We subscribe, therefore, to the belief that anti- 
thrombin  is not serum albumin,  but some unknown factor which may or 
may not be associated with it. 
Since  Quick's  experiments  (29),  like  those  of  M0rawitz  (25),  support 
claims for antithrombin  in  plasma  by procedures  involving a preliminary 
TABLE  V 
The Relationship be~een k and the Concentralion of Trypsin 
(Da~a Taken from Fig. 4) 
Trylnin micrograms  per 100 cc.  k X 104 observed  k X 104 calculated* 
1000 
500 
250 
125 
0 
325 
172 
114 
80 
33 
314 
174 
104 
69 
34 
* The ca/c~dated value for k was obtained  by assuming that  a  direct  relationship 
existed between k and the concentration of trypsin.  The equation for the straight line 
was used: 
yffiffiax+b 
where y  ffi k; a  ffi 0.028; b  •ffi  3.4; 
and  x •ffi  the trypsin concentration. 
defibrination,  it  cannot  be  asserted  with  any  degree  of  certainty  that 
untreated  plasma  contains  an  active  antithromhin.  Some of our  results 
indicate that the antithrombin in plasma is present as an inactive substance. 
The present kinetic studies on serum antithrombin involve two methods, 
(a)  following  the  concentration  of  thrombin  present  in  serum  from  the 
earliest  practicable  moment  after  defibrination,  and  (b)  adding  varying 
amounts of a  thrombin-free  (tested) serum to a  known thrombin prepara- 
tion. 
Preparalbm of Serum.--Acetone-thromboplastin (see reagents)  is added  to citrated 
plasma diluted  with 0.85 per cent NaCI, and  recalcified with  an optimal amount  of 
CaCI2.  The fibrin is removed with a glass rod as fast as it is formed.  The addition of a 
few drops of thrombin to a sample of the final serum confirms the completeness of the 
defibrination. 182  KINETICS  OF  THROMBIN  INACTIVATION 
Tests.--(a)  Immediately upon completion of the defibrination, 0.5 cc. of serum is 
added to  1 cc.  of fibrinogen solution, under the  conditions previously described for 
thrombin assay, and the test is repeated at various time intervals.  (b) For the second 
series of experiments, increasing  amounts of serum (thrombin-free,  by tests on fibrinogen) 
are added to thrombin and the kinetics followed  in the usual way. 
(a).--Table  VI  shows  that  the  inactivation rate  constant  (k)  for  the 
naturally occurring thrombin of serum is exceedingly high.  The inactiva- 
tion rate for thrombin in serum appears to be directly dependent upon the 
initial concentration of the plasma. 
Hemophilia.--The  serum from a  citrated hemophilic plasma was diluted 
tenfold and clotted by CaCI~, both with and without added thromboplastin. 
TABLE  VI 
Rate of Thrombin Inactivation in Serum (pH  = 7.4; Temperature = 38  °) 
Brain thromboplastin was added  to  dog plasma before recalcifying.  Incubation 
time is given in minutes, measured from the time of recalcification.  The clotting time 
is given in seconds in the body of the table. 
I  Dilutions  Incubation time 
2'  2.5'  3'  4'  5'  6'  6.5.___.~'  [__[  k × 104  of_ p]a,sma  1.5'_.'_  ......  8' 
1:1  I  --  ]  --  ,  --  ]  2"  27"  ,  --  [  oo  ]  I  Veryhigh 
1:2  --  19"  123"  JaY'  ]77"  1102"  [135"  [  4690 
1:4  22"  so"  I  -  I  45"  I  68"  93"  I  113"  I  3060 
"1:8  I  --  I  22"  I  --  133"150"1  73"1  --  1105"  1135"  I  2800 
In each case the k value was 0.206.  This indicates that the antithrombic 
factor is normal in hemophilic serum. 
(b).--In  Table  VII,  increasing  amounts  of  thrombin-free  serum  were 
added to a thrombin solution and the kinetics of inactivation studied.  The 
results clearly show the ability of serum to increase the thrombin inactiva- 
tion rate.  The k value rises in direct proportion to the amount of serum 
added.  It may also be noted that the 24 hour old serum preparation used 
for the data of Table VII, Series B, is much weaker than the fresh serum of 
Table VII, Series A.  This suggests a lability of the thrombinolytic factor 
in serum and lessens the bare possibility of the inactivation process being 
some sort of combination or adsorption on to  the serum proteins (19, 31). 
The inability to reactivate serum-lysed thrombin with alkali or  acid  (cf. 
"metathrombin," 25,  17) also argues strongly against a  non-lyric inactiva- 
tion  mechanism. 
The rate  of decrease  of the antithrombic  a~ti~ty of serum was studied at 
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sample, held at the chosen pH for the cited times, was added to 5  cc. of a 
stable thrombin, buffered at pH  =  7.6 with imidazole buffer (see reagents). 
TABLE  VII 
Influence of Serum on k.  pH  =  7.2, Temperature  =  38  ° 
Clotting times (seconds) given in body of tables. 
A.  Fresh Serum (Thrombin-Free) 
Cc. serum added  k X  104 
to 40 cc.  Saline  (approximate) 
thrombin  1  '  11  ' 
2 
4 
8 
16 
CO. 
14 
12 
8 
0 
68" 
73" 
90" 
100" 
Incubation time (minutes) 
3'  6' 
85"  112" 
103"  106" 
122"  ~o 
160" 
173 °  1010 
1560 
1920 
2350 
B.  Aged Serum (g4 Hrs. at 9°C. Thrombin-Free) 
Cc. of 
serum 
added to 
40 cc. 
thrombin 
Saline 
cc. 
0  2.00 
0.12  1.88 
0.25  1.75 
0.50  1.50 
1.00  1000 
2.00 
0 t 
40- 
10' 
44" 
52" 
55" 
52" 
64" 
66" 
Incubation time (minutes) 
21' 
68" 
72" 
78" 
95" 
135" 
24' 
66" 
39' 
82" 
100" 
110" 
145" 
184" 
o. 
50' 
103" 
66' 
170" 
210" 
kX104 
(approxi- 
mate) 
220 
240 
240 
350 
360 
650 
TABLE  VIII 
Inactivation of Serum "Antithrombin" 
The body of the table gives the (k  ×  104) values obtained by the addition of 1 co. 
serum (after the cited time of incubation, at 38  ° and the given pH) to 5 co. of thrombin. 
The thrombin and fibrinogen solution were buffered with N/10 imidazole to pH 7.6. 
Incubation of serum (minutes) 
pH  30'  83'  137' 
2.0 
3.9 
5.4 
7.4 
9.8 
0 
242 
426 
288 
920 
0 
87 
487 
365 
642 
0 
0 
386 
253 
437 
The  thrombin  inactivation  rates  were  determined  in  the  usual  manner. 
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Although more antithrombic activity was initially present at pH  =  9.8 
than in  sera kept at  low pH  values,  there was more rapid  loss of anti- 
thrombic activity at  the most alkaline pH.  At pH  5.4  and  7.4 a  small 
increase in  antithrombic  activity is  apparent.  At pH  values  below 4.0, 
there was practically no antithrombic activity.  This was not due to the 
previously described  effect of acids  on  thrombin  (see  above),  since  the 
thrombin itself was well buffered at pH  =  7.6.  The sera kept for over 2 
hours at pH levels of 2.0 and 3.9 did not regain their antithrombic activity 
during the incubation with the thrombin at pH  =  7.6.  However, the loss 
of antithrombin is reversible,  under appropriate  conditions, as shown by 
the data of Table IX. 
Here the serum was brought  to pH  =  1.7.  After standing for about 
10 minutes, a  portion was brought to pH  =  9.6 and allowed to stand at 
TABLE  IX 
The Reactivation of Serum Antithrombin 
Clotting times (seconds) given in body of table. 
pH of added serum 
1.7 
Readjusted to 9.6 
No serum added 
Incubation time (minutes) m serum -J- thrombln  k X 104 (ap- 
88"  80"  78"  I  76"  I  73"  I  75n  ]  -- 
90"  92"  110"  [  145"  1190"  1250"  I  48O 
i  90"  i  90-  i  88-  i  85,,  i  80"  i  80"  i  - 
38°C., for 30 minutes; the rest was kept (at pH  =  1.7) as a control.  1 cc. 
of each sample was then added to 5 cc. of thrombin, at pH  =  7.6, and the 
thrombin inactivation rate measured as before.  The alkalinized prepara- 
tion recovered a marked degree of antithrombic activity, whereas there was 
a complete absence of antithrombin in the acid sample, as seen by comparing 
with the thrombin control.  The similarity of these pH effects to those ob- 
taining with trypsin (Northrop, 26) is remarkable. 
DISCUSSION 
It  is  evident from the foregoing experiments that  prepared  thrombins 
undergo progressive inactivation, following the course of a first order reac- 
tion.  By computing the velocity constant (k) from kinetic data, the proc- 
ess may be characterized independently of the factor of thrombin concen- 
tration.  Since  k  may  vary  greatly  in  thrombins  which  are  similar  in 
initial activity, there is strong evidence for a  thrombinolytic factor, which 
varies from preparation to preparation.  The obvious suggestion is that it 
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The proteolytic enzyme trypsin is an example of added impurity, which 
can alter the kinetic behavior of a  stable thrombin to that of one which is 
much less  stable.  The  so called  antithrombic  action  of serum  closely re- 
sembles that of trypsin in the studies we have made concerning its kinetic 
aspects.  The  physical  conditions  of  temperature  and  pH,  which  are  so 
important  in  thrombin  formation,  are  no  less  significant  in  modifying 
thrombin  inactivation.  Whereas  the  most  stable  thrombins  retain  their 
activity  over  a  wide  pH  range  (5.0-10.0),  the  less  stable  preparations 
(including those to which trypsin or serum has been added)  show a  maxi- 
mum stability at pH  =  4-5. 
The  chief interest  in  the  facts herein  presented  lies in  the explanation 
which must be offered to account for them and in the  future lines of en- 
quiry to which they clearly point.  Chief among the latter will be the at- 
tempt to isolate the thrombin impurity  (antithrombin),  which is indicated 
by the  data.  Pending  the outcome of investigations  now proceeding,  by 
which it is hoped to characterize  the thrombinolytic factor from the view- 
point of its proteolytic activities, we are advancing only tentatively the con- 
clusion that progressive antithrombic action may be due to an enzyme im- 
purity  in  the  thrombin  (and  prothrombin)  preparations? 
The following summarized  points constitute  the present evidence in sup- 
port of this conclusion: 
1.  Added trypsin,  like  serum antithrombin,  converts a  stable thrombin 
into an unstable one, with a  marked increase in the inactivation  rate con- 
stant. 
2.  The acidic region  (pH  =  4-5) at which unstable thrombins are most 
slowly inactivated is the pH zone at which the effects of trypsin and serum 
are minimal.  Northrop  (26) has pointed out that pure trypsin is inactive 
in  this  pH  region. 
3.  The inactivating agent (serum antithrombin) appears to be most stable 
at pH 5  to 6. 
4.  The unimolecular behavior of the inactivation  process, together with 
the  effects of varying physical conditions,  are  wholly consistent with  the 
enzyme  hypothesis. 
It  is not intended  to place  the  whole burden  of thrombin  inactivation 
upon the postulated thrombinolytic enzyme.  The slow deterioration of the 
8  A careful search of the literature, following the completion of this paper, brought to 
light very little  to suggest an enzymatic nature  of antithrombin,  with the important 
exception of a long-forgotten contribution by Collingwood  and MacMahon (4), to whom 
must be given due credit for conclusions very similar to those herein presented, even to 
the analogy between serum antithrombin  and pancreatic  trypsin. 186  KINETICS  OF  THROMBIN  INACTIVATION 
more stable thrombins may very well be a protein denaturation.  Thermal 
denaturation  of  proteins,  enzymes,  and  viruses  (some  of  which are  now 
known to be proteins)  follows a  very similar course.  The rapid inactiva- 
tion, especially at moderate temperatures, in the physiological pH range, 
is the main reason, apart from the analogies outlined above, for postulating 
a  specific thrombinolytic factor. 
We do not know what thrombin is, but all the available evidence indi- 
cates  that it is a  protein,  or  so  closely bound up with proteins as  to be 
affected by their susceptibility to denaturation  and proteolysis.  Throm- 
bin may also be an enzyme, although definite proof for, or against,  this is 
still lacking (27).  We have previously (11) advanced the idea that another 
type of enzyme, viz.  a  thromboplastic enzyme, accompanies  (crude)  pro- 
thrombin and, in conjunction with ionized calcium and phospholipid (ceph- 
alin),  activates  it  to  thrombin.  The  present  data  indicate  yet  another 
enzymatic  function,  namely,  thrombinolytic.  This  need  not  complicate 
the picture unduly, if it should turn out to be identical with the thrombo- 
plastic  factor,  and  especially  if  both  are  tryptic.  Plasma  tryptases  are 
already known (Schmitz, 33) and might very well be expected to accompany 
plasma  prothrombin  and  thrombin  preparations.  Schmitz's  work  raises 
the  question  of  the  r61e  of  specific inhibitors  (antitrypsins),  and  kinase 
factors,  in  these  new  functions we  are  postulating  for  plasma  tryptase. 
Upon the answer to this question may hinge the explanation  of the con- 
tinued fluidity of the blood in vivo.* 
Tissue  (including platelet  and  possibly  leucocyte)  sources  of  protease 
are  not  immediately involved in  our  Berkefelded plasma  reagents,  with 
cephalin as the only added  thromboplastic agent.  However,  tissue anti- 
thrombins  have  been  described  in  the  literature.  These  may  very well 
depend upon artificial methods of preparation and will require more exten- 
sive  investigation  than  the  data  here  presented.  It  may  be  significant 
that brain extracts are known to contain an antitrypsin (28).  The data of 
Fig. 2 and Table III do not lend strong support to Howell's view that throm- 
boplastin  "neutralizes"  antithrombin,  but  Howell  himself  had  certain 
doubts,  e.g.,  the inability of cephalin to overcome the serum inhibitor of 
fully formed thrombin  (17). 
It  is  not  proposed  to  take  up  space  to  contrast  our  thrombinolytic 
antithrombin theory  with older views which postulate  a  loose thrombin- 
antithrombin  "combination"  (?  metathrombin  formation).  Our  inac- 
tivated thrombins are irreversible and unaffected by treatment with alkali 
4 Some of our recent experiments  (Glazko, A. J., and Ferguson, J.  H.,  Proc. Soc. 
Exp. Biol.  and Med.,  1940,  45, 43)  show that  heparin  inhibits  the  action  of  trypsin 
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and acid (of.  metathrombin).  All the evidence points to the progressive 
action of a specific antithrombin, rather than to the progressive production 
of an immediate antithrombin. 
We have often observed that  clots formed in the presence of unstable 
thrombins  are  especially  liable  to  undergo  fibrinolysis.  Correlation of 
fibrinolysis with thrombinolysis is, therefore, suggested. 
We are currently engaged in an attempt to use the basic methods of this 
paper  in  a  simple  clinical  test  for  progressive  antithrombins.  Provided 
that a  practical  thrombin unit can be  (empirically) established, a  unit of 
antithrombin can readily be defined from equation 10. 
SUMMARY 
1.  A new technique for studying the progressive inactivation of thrombin 
is  described. 
2.  Thrombin inactivation follows the kinetics of a  first order reaction. 
3.  The rate constant of the inactivation reaction increases with tempera- 
ture and pH (5.0 --+ 10.0), and also with the presence of crystalline trypsin, 
or serum.  The rate varies for different thrombin preparations, even under 
the  same  experimental  conditions. 
4.  The temperature characteristics of  the reaction indicate that throm- 
bin is associated with protein. 
5.  Thrombin preparations are most stable at pH 4 to 5, even when tryp- 
sin or  serum is added. 
6.  The progressive inactivation is believed to be due to two mechanisms: 
(1) a major effect, thought to be the action of a  "serum-tryptase," which is 
usually present in the thrombin preparations, and (2) a minor effect, prob- 
ably  attributable  to denaturation of thrombin-protein. 
7.  Sources  of  the  thrombinolytic  factor  (serum-tryptase)  and  its  im- 
plications in the general theory and practical problems of blood coagulation 
and antithrombic action are briefly discussed. 
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